Tamáriz-Campillo AF, Armendáriz BY, Pérez CAE, Escandón PS, Vega MME, Toussaint-Caire S

Language: Spanish
References: 11
Page: 140-143
PDF size: 191.92 Kb.

ABSTRACT

The term pseudolymphoma or cutaneous lymphomatoid reaction refers to benign cutaneous lymphoid proliferations that mimic cutaneous lymphomas, both clinically and histopathologically. They tend to be triggered by various agents, such as drugs. We present a 24-year-old female hospitalized for autoimmune encephalitis and refractory status epilepticus, managed with multiple drugs (anticonvulsants, benzodiazepines, antidepressants and, antibiotics). During her hospitalization, she developed a skin rash; skin biopsy revealed a cutaneous pseudolymphoma. The intention of this clinical case is to address the clinical and pathological aspects of druginduced pseudolymphoma and its associated cd30+ expression.

REFERENCES

1. Magro CM, Crowson AN, Kovatich AJ y Burns F, Drug-inducedreversible lymphoid dyscrasia: a clonal lymphomatoid dermatitisof memory and activated t cells, Hum Pathol 2003; 34(2):119-29.

2. Romero-Pérez D, Blanes-Martínez M y Encabo-Durán B, Cutaneouspseudolymphomas, Actas Dermosifiliogr 2016; 107(8):640-51.

3. Pulitzer MP, Nolan KA, Oshman RG y Phelps RG, cd30+ lymphomatoiddrug reactions, Am J Dermatopathol 2013; 35(3):343-50.

4. Magro CM, Daniels BH y Crowson AN, Drug induced pseudolymphoma,Semin Diagn Pathol 2018; 35(4):247-59.

5. Ploysangam T, Breneman DL y Mutasim DF, Cutaneous pseudolymphomas,J Am Acad Dermatol 1998; 38(6):877-98.

6. Bocquet H, Bagot M y Roujeau JC, Drug-induced pseudolymphomaand drug hypersensitivity syndrome (drug rash with eosinophiliaand systemic symptoms: dress), Semin Cutan MedSurg 1996; 15(4):250-7.

7. Magro CM, Olson LC, Nguyen GH y De Feraudy SM, cd30 positivelymphomatoid angiocentric drug reactions: characterizationof a series of 20 cases, Am J Dermatopathol 2017; 39(7):508-17.

8. Cepeda LT, Pieretti M, Chapman SF y Horenstein MG, cd30-positive atypical lymphoid cells in common non-neoplastic cutaneousinfiltrates rich in neutrophils and eosinophils, Am J SurgPathol 2003; 27(7):912-8.

9. Albrecht J, Fine LA y Piette W, Drug-associated lymphoma andpseudolymphoma: recognition and management, Dermatol Clin2007; 25(2):233-44.

10. Bergman R, Pseudolymphoma and cutaneous lymphoma: factsand controversies, Clin Dermatol 2010; 28(5):568-74.

11. Miguel D, Peckruhn M y Elsner P, Treatment of cutaneous pseudolymphoma:a systematic review, Acta Derm Venereol 2018;13,98(3):310-7.